Treatments composed of mixture of cytokines, growth factors and other active components
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
159
NCT04277598
A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Oct 9, 2020
Completion: Dec 6, 2023
Loading map...